Latest news with #WahaCapital
Khaleej Times
21-05-2025
- Business
- Khaleej Times
Orchid Fertility unveils advanced facility in Dubai Healthcare City
Orchid Fertility has moved into a state-of-the-art facility in Dubai Healthcare City. This move enhances the clinic's capacity and infrastructure, driven by sustained annual growth and rising demand —further cementing Dubai's status as a global hub for specialised healthcare. 'Orchid is a key asset within Waha Health, our healthcare investment platform and this milestone reflect the business's strong execution and sustained growth trajectory,' said Mohamed Hussain Al Nowais, Managing Director at Waha Capital. 'We are proud to support Orchid's continued expansion as it strengthens its market position and delivers long-term value through clinical excellence, innovation and a deeply patient-centric approach.' The newly launched clinic is designed to provide a streamlined, supportive, and deeply personalized fertility journey. It features an advanced IVF lab with cutting-edge embryology and andrology labs, private consultation rooms, recovery suites, and dedicated spaces for emotional and wellness support—recognizing that fertility is as much an emotional experience as it is a medical one. 'At Orchid, our work begins with empathy and is guided by science,' said Dr. Dimitrios Kafetzis, Medical Director and Consultant in Reproductive Endocrinology and Infertility at Orchid Fertility. 'This new facility enables us to deepen that commitment, offering improved outcomes and comfort to patients. Whether someone is taking their first steps in fertility treatment or seeking answers after a long journey, Orchid is where hope finds direction.' Known for its clinical excellence and compassionate approach, Orchid Fertility boasts one of the highest success rates in the UAE—with a 71% pregnancy rate across all age groups, well above industry averages. Its team of leading fertility specialists are highly experienced in treating complex cases, using the latest technology and evidence-based approaches to deliver hope and results to couples who have struggled for years. 'Dubai is a city that thrives on innovation, excellence and inclusivity,' said Dr. Arpan David, CEO of Orchid Fertility. 'It's the perfect place for us to continue our growth journey. Our team, infrastructure, and medical capabilities have evolved to support every patient with personalised, high-quality care.' The clinic's services include fertility preservation, male infertility treatment, genetic testing, embryo freezing, and advanced IVF procedures—all backed by a multidisciplinary team and supported by a compassionate care model. Beyond medicine, Orchid offers holistic support including counseling, mindfulness sessions, and lifestyle coaching to ease the emotional toll of fertility treatment. 'The rising demand for fertility care reflects changing lifestyles, delayed parenthood and greater awareness,' added Dr. Partha Das, Deputy Medical Director, Consultant Reproductive Endocrinology and Infertility. 'Orchid's enhanced capabilities ensure that we're well-positioned to extend care to a broader and more diverse group of patients—especially those who have experienced setbacks or are navigating complex fertility challenges.' With expanded capacity and streamlined scheduling, patients can now access consultations faster than ever before. 'At Orchid, we don't just offer treatment—we offer hope, direction, and unwavering support,' said Dr. Arpan David. 'This new facility is a reflection of our values: advanced, warm, and deeply human.' As demand for fertility services continues to grow across the UAE, Orchid Fertility's expansion marks a bold step forward in shaping the future of reproductive health—where innovation meets empathy, and outcomes change lives. Orchid's growth reflects Waha Capital's broader ambition to scale its healthcare investment platform and invest in businesses with scalable, impact-driven models. Orchid Fertility is accredited by the College of American Pathologists (CAP) and Joint Commission International (JCI) —globally recognized seals of excellence that reflect Orchid's excellence across clinical practices, infrastructure, and operations.
Zawya
21-05-2025
- Business
- Zawya
Orchid Fertility unveils advanced facility in Dubai Healthcare City, redefining fertility care in the Middle East
With cutting-edge tech, compassionate care, and one of the region's highest IVF success rates, Orchid aims to redefine fertility care in the Middle East. Dubai, UAE – Orchid Fertility, one of the region's most trusted names in reproductive health, has moved into a state-of-the-art facility in Dubai Healthcare City, designed to elevate patient experience and outcomes. This move enhances the clinic's capacity and infrastructure, driven by sustained annual growth and rising demand for high-quality, patient-centered fertility services—further cementing Dubai's status as a global hub for specialised healthcare. The facility was inaugurated in the presence of senior dignitaries from the UAE's healthcare sector, including officials from the Dubai Healthcare City Authority, the Managing Director and senior executives of Waha Capital as Orchid's shareholder, and the clinic's leadership team 'Orchid is a key asset within Waha Health, our healthcare investment platform and this milestone reflect the business's strong execution and sustained growth trajectory,' said Mr. Mohamed Hussain Al Nowais, Managing Director at Waha Capital. 'We are proud to support Orchid's continued expansion as it strengthens its market position and delivers long-term value through clinical excellence, innovation and a deeply patient-centric approach.' The newly launched clinic is designed to provide a streamlined, supportive, and deeply personalized fertility journey. It features an advanced IVF lab with cutting-edge embryology and andrology labs, private consultation rooms, recovery suites, and dedicated spaces for emotional and wellness support—recognizing that fertility is as much an emotional experience as it is a medical one. 'At Orchid, our work begins with empathy and is guided by science,' said Dr. Dimitrios Kafetzis, Medical Director and Consultant in Reproductive Endocrinology and Infertility at Orchid Fertility. 'This new facility enables us to deepen that commitment, offering improved outcomes and comfort to patients. Whether someone is taking their first steps in fertility treatment or seeking answers after a long journey, Orchid is where hope finds direction.' Known for its clinical excellence and compassionate approach, Orchid Fertility boasts one of the highest success rates in the UAE—with a 71% pregnancy rate across all age groups, well above industry averages. Its team of leading fertility specialists are highly experienced in treating complex cases, using the latest technology and evidence-based approaches to deliver hope and results to couples who have struggled for years. 'Dubai is a city that thrives on innovation, excellence and inclusivity,' said Dr. Arpan David, CEO of Orchid Fertility. 'It's the perfect place for us to continue our growth journey. Our team, infrastructure, and medical capabilities have evolved to support every patient with personalised, high-quality care.' The clinic's services include fertility preservation, male infertility treatment, genetic testing, embryo freezing, and advanced IVF procedures—all backed by a multidisciplinary team and supported by a compassionate care model. Beyond medicine, Orchid offers holistic support including counseling, mindfulness sessions, and lifestyle coaching to ease the emotional toll of fertility treatment. 'The rising demand for fertility care reflects changing lifestyles, delayed parenthood and greater awareness,' added Dr. Partha Das, Deputy Medical Director, Consultant Reproductive Endocrinology and Infertility. 'Orchid's enhanced capabilities ensure that we're well-positioned to extend care to a broader and more diverse group of patients—especially those who have experienced setbacks or are navigating complex fertility challenges.' With expanded capacity and streamlined scheduling, patients can now access consultations faster than ever before. 'At Orchid, we don't just offer treatment—we offer hope, direction, and unwavering support,' said Dr. Arpan David. 'This new facility is a reflection of our values: advanced, warm, and deeply human.' As demand for fertility services continues to grow across the UAE, Orchid Fertility's expansion marks a bold step forward in shaping the future of reproductive health—where innovation meets empathy, and outcomes change lives. Orchid's growth reflects Waha Capital's broader ambition to scale its healthcare investment platform and invest in businesses with scalable, impact-driven models. Orchid Fertility is accredited by the College of American Pathologists (CAP) and Joint Commission International (JCI) —globally recognized seals of excellence that reflect Orchid's excellence across clinical practices, infrastructure, and operations.
Zawya
19-05-2025
- Business
- Zawya
Waha Capital's net profits plunge 44% in Q1-25
Abu Dhabi: Waha Capital generated AED 157.52 million in the first quarter (Q1) of 2025, lower by 44% than AED 281.08 million in Q1-24. The company generated revenues amounting to AED 329.86 million as of 31 March 2025, down 29% year-on-year (YoY) from AED 464.75 million, according to the financial results. Basic and diluted earnings per share (EPS) declined to AED 0.04 in Q1-25 from AED 0.08 a year earlier. Mohamed Hussain Al Nowais, Managing Director of Waha Capital, stated that the group delivered robust growth in Q1-25, posting net profit of AED 81 million and maintaining a healthy return on average equity of 7.80%. 'Waha Investment and its funds continued to attract strong global institutional interest, with third-party assets under management rising to AED 7.20 billion from AED 6 billion a year earlier,' Hussain added. He concluded: 'This growth drove Waha Capital's total assets under management [AUM] to AED 12.30 billion by the end of Q1-25 – an 11% increase from AED 11.10 billion a year ago - underscoring investor confidence in our track record and approach.' Last year, the net profits attributable to the shareholders of Waha Capital dropped by 13.40% to AED 381.27 million from AED 440.10 million in 2023.
Al Bawaba
18-05-2025
- Business
- Al Bawaba
Waha Capital Delivers Strong First Quarter Performance with Net Profit Attributable to Shareholders of AED 81 Million
Waha Capital PJSC, an Abu Dhabi-listed investment management company (ADX: WAHA), reported net profit attributable to shareholders of AED 81 million, translating to a return on average equity of 7.8%. This was supported by gains in the company's public markets business, value realisation from the Private Investments portfolio, and steady rental income from Waha Land. During the first quarter, the company's total income stood at AED 330 million, demonstrating an ability to deliver consistent earnings across market cycles through the balanced contribution of all three business pillars. The company's total assets under management (AUM) stood at AED 12.3 billion as of 31 March 2025, an increase of 2.9% from AED 11.9 billion at the end of 2024, supported by strong inflows of third-party capital into Waha Investment's funds. In recognition of Waha Capital's multi-year track record of achievement, the company was ranked among Forbes Middle East's Top 40 Asset Managers in 2025 for the fourth consecutive year. Meanwhile, Waha Capital continued to activate corporate social responsibility initiatives aligned with the United Nations Sustainable Development Goals, particularly SDG 1 (No Poverty) and SDG 2 (Zero Hunger). In collaboration with the Authority of Social Contribution - Ma'an, Waha Capital supported two impactful Ramadan initiatives aimed at helping underprivileged communities in Abu Dhabi and Al Ain. The Food ATM initiative provided subsidized Iftar meals for blue-collar and low-income workers, while the Nourishment for Goodness initiative supported low-income families through food basket distributions and the renovation of homes to improve living conditions. Waha Investment Highlights Waha Investment, the wholly owned asset management subsidiary of Waha Capital, recorded net profit of AED 91 million in the first quarter of 2025. This was supported by recurring fee income, as third-party AUM increased to AED 7.2 billion as of 31 March 2025 from AED 6.0 billion a year earlier. Today, third-party AUM is diversified across a broad base of regional and global clients, including sovereign wealth funds, pension funds, insurance companies, private banks, family offices, and high net worth individuals. The flagship Waha Emerging Markets Credit Fund, which pursues diverse long-short strategies in emerging markets fixed income, has now recorded a cumulative net return of 270.7% since its inception in 2012, in comparison to the 66.4% return of its benchmark, the JPMorgan EMBI Global Diversified Index. The Waha MENA Equity Fund has produced a cumulative net return of 383.3% since its inception in 2014, significantly outperforming its benchmark S&P Pan Arab Composite Index, which posted a return of 85.8% in the same period. Meanwhile, the Waha Islamic Income Fund, which is focused on global sukuk and Shari'ah-compliant equities, has recorded a cumulative net return of 29.0% since its inception in 2020, compared to 6.0% for its reference, the Dow Jones Sukuk Index. Private Investments Highlights The Private Investments business, which follows a flexible, multi-asset strategy across sectors and geographies, delivered net profit of AED 16 million in Q1 2025. This was primarily driven by the successful partial strategic exit from one of its investments. While the broader portfolio was affected by continued mark-to-market volatility across asset classes and regions, the underlying assets remain well-positioned to create value over the investment cycle. Waha Health, Waha Capital's wholly owned healthcare platform, reached a key milestone with the announced expansion of Orchid Fertility, one of Dubai's fastest-growing IVF clinics. The new, purpose-built facility, set to officially open on 21 May, reflects rising patient demand and the clinic's growing team of medical specialists. With a 71% success rate, well above the international average, Orchid embodies Waha Capital's strategy of investing in high-growth, high-impact sectors while supporting the UAE's ambition to develop a world-class healthcare ecosystem. As of 31 March 2025, the Private Investments team managed AED 628 million in assets and remains focused on disciplined capital deployment, opportunistic exits, and maximizing shareholder value through selective new investments and active portfolio management. Waha Land Highlights Waha Land, a wholly owned subsidiary of Waha Capital, reported net profit of AED 11 million in Q1 2025, representing 10% growth versus the same period last year. The company's flagship industrial development, ALMARKAZ, continues to benefit from strong leasing momentum and a diversified, high-quality tenant base, with occupiers from sectors including oil & gas, manufacturing, and logistics. Stages 1 and 2A are nearly at full occupancy, with almost 100% leasing across a combined 180,400 m² of space. Stage 2B, completed in Q1 2024, introduced an additional 75,600 m² of high-specification industrial units and has already reached 76% occupancy. Waha Land remains focused on unlocking further value from the ALMARKAZ platform, including evaluating potential monetization of income-generating assets. This strategy is aligned with rising market demand for logistics and light industrial facilities, supported by Abu Dhabi's economic diversification and the UAE's role as a growing hub for regional trade.
Zawya
16-05-2025
- Business
- Zawya
Waha Capital delivers strong first quarter performance with net profit attributable to shareholders of AED81mln
Q1 2025 Key Highlights Waha Investment recorded Q1 net profit of AED 91 million, driven by recurring management and performance fees from its flagship emerging markets equity and fixed income hedge funds. Private Investments business generated Q1 net profit of AED 16 million, following a partial exit from one of its investments. Waha Land continued to deliver stable income, supported by increased leasing activity from Stage 2B, resulting in net profit of AED 11 million. Waha Capital was ranked among Forbes Middle East's Top 40 Asset Managers in 2025 for the fourth consecutive year. (AED million) Q1 2025 Q1 2024 % Change (YoY) Total Income 330 465 (29%) Expenditures (96) (103) 7% Finance cost (77) (80) 4% Net Profit/Loss 157 281 (44%) Net Profit Attributable to Shareholders 81 166 (51%) Return On Investments (1) 11.5% Average ROE (3) 7.8% Average ROA (4) 3.9% Total Assets Under Management (2) AED 12.3bn 1 Based on prior four quarters' investment return. 2 As of 31 March 2025, including assets managed on behalf of third parties across all businesses. 3 Based on prior four quarters' contribution to Waha Capital shareholders. 4 Based on prior four quarters' contribution to all shareholders, including minorities. Waha Capital delivered robust growth in the first quarter of 2025, posting net profit of AED 81 million and maintaining a healthy return on average equity of 7.8%. All three strategic pillars - Waha Investment, Private Investments, and Waha Land - contributed to this performance, reaffirming the strength of our diversified business model. Waha Investment and its funds continued to attract strong global institutional interest, with third-party assets under management rising to AED 7.2 billion from AED 6.0 billion a year earlier. This growth drove Waha Capital's total assets under management to AED 12.3 billion by the end of Q1 2025 - an 11% increase from AED 11.1 billion a year ago - underscoring investor confidence in our track record and approach. Private Investments reinforced its role as a reliable engine of diversification, with value realised through the targeted monetisation of portfolio assets. In line with our commitment to back high-impact, value-driven investments, our healthcare asset, Orchid Fertility, announced plans to expand into a new, larger facility, supporting its trajectory as one of Dubai's fastest-growing clinics. Meanwhile, Waha Land continued to maximise the potential of our real estate portfolio, with leasing levels nearing full occupancy in Stages 1 and 2A of ALMARKAZ, and 76% leasing achieved in Stage 2B. Looking ahead, we will remain proactive in navigating an uncertain macroeconomic environment with discipline and resilience. Waha Capital's diversified platform, proven track record, commitment to stakeholders, and strong investment approach, positions us well to continue delivering sustainable long-term value for our shareholders. Abu Dhabi – Waha Capital PJSC, an Abu Dhabi-listed investment management company (ADX: WAHA), reported net profit attributable to shareholders of AED 81 million, translating to a return on average equity of 7.8%. This was supported by gains in the company's public markets business, value realisation from the Private Investments portfolio, and steady rental income from Waha Land. During the first quarter, the company's total income stood at AED 330 million, demonstrating an ability to deliver consistent earnings across market cycles through the balanced contribution of all three business pillars. The company's total assets under management (AUM) stood at AED 12.3 billion as of 31 March 2025, an increase of 2.9% from AED 11.9 billion at the end of 2024, supported by strong inflows of third-party capital into Waha Investment's funds. In recognition of Waha Capital's multi-year track record of achievement, the company was ranked among Forbes Middle East's Top 40 Asset Managers in 2025 for the fourth consecutive year. Meanwhile, Waha Capital continued to activate corporate social responsibility initiatives aligned with the United Nations Sustainable Development Goals, particularly SDG 1 (No Poverty) and SDG 2 (Zero Hunger). In collaboration with the Authority of Social Contribution - Ma'an, Waha Capital supported two impactful Ramadan initiatives aimed at helping underprivileged communities in Abu Dhabi and Al Ain. The Food ATM initiative provided subsidized Iftar meals for blue-collar and low-income workers, while the Nourishment for Goodness initiative supported low-income families through food basket distributions and the renovation of homes to improve living conditions. Waha Investment Highlights Waha Investment, the wholly owned asset management subsidiary of Waha Capital, recorded net profit of AED 91 million in the first quarter of 2025. This was supported by recurring fee income, as third-party AUM increased to AED 7.2 billion as of 31 March 2025 from AED 6.0 billion a year earlier. Today, third-party AUM is diversified across a broad base of regional and global clients, including sovereign wealth funds, pension funds, insurance companies, private banks, family offices, and high net worth individuals. The flagship Waha Emerging Markets Credit Fund, which pursues diverse long-short strategies in emerging markets fixed income, has now recorded a cumulative net return of 270.7% since its inception in 2012, in comparison to the 66.4% return of its benchmark, the JPMorgan EMBI Global Diversified Index. The Waha MENA Equity Fund has produced a cumulative net return of 383.3% since its inception in 2014, significantly outperforming its benchmark S&P Pan Arab Composite Index, which posted a return of 85.8% in the same period. Meanwhile, the Waha Islamic Income Fund, which is focused on global sukuk and Shari'ah-compliant equities, has recorded a cumulative net return of 29.0% since its inception in 2020, compared to 6.0% for its reference, the Dow Jones Sukuk Index. Private Investments Highlights The Private Investments business, which follows a flexible, multi-asset strategy across sectors and geographies, delivered net profit of AED 16 million in Q1 2025. This was primarily driven by the successful partial strategic exit from one of its investments. While the broader portfolio was affected by continued mark-to-market volatility across asset classes and regions, the underlying assets remain well-positioned to create value over the investment cycle. Waha Health, Waha Capital's wholly owned healthcare platform, reached a key milestone with the announced expansion of Orchid Fertility, one of Dubai's fastest-growing IVF clinics. The new, purpose-built facility, set to officially open on 21 May, reflects rising patient demand and the clinic's growing team of medical specialists. With a 71% success rate, well above the international average, Orchid embodies Waha Capital's strategy of investing in high-growth, high-impact sectors while supporting the UAE's ambition to develop a world-class healthcare ecosystem. As of 31 March 2025, the Private Investments team managed AED 628 million in assets and remains focused on disciplined capital deployment, opportunistic exits, and maximizing shareholder value through selective new investments and active portfolio management. Waha Land Highlights Waha Land, a wholly owned subsidiary of Waha Capital, reported net profit of AED 11 million in Q1 2025, representing 10% growth versus the same period last year. The company's flagship industrial development, ALMARKAZ, continues to benefit from strong leasing momentum and a diversified, high-quality tenant base, with occupiers from sectors including oil & gas, manufacturing, and logistics. Stages 1 and 2A are nearly at full occupancy, with almost 100% leasing across a combined 180,400 m² of space. Stage 2B, completed in Q1 2024, introduced an additional 75,600 m² of high-specification industrial units and has already reached 76% occupancy. Waha Land remains focused on unlocking further value from the ALMARKAZ platform, including evaluating potential monetization of income-generating assets. This strategy is aligned with rising market demand for logistics and light industrial facilities, supported by Abu Dhabi's economic diversification and the UAE's role as a growing hub for regional trade. About Waha Capital Waha Capital is an Abu Dhabi-listed investment management company that leverages its emerging markets expertise, business networks and research capabilities to deliver attractive returns to shareholders and investors in its funds. Founded in 1997, Waha Capital is one of the Emirate's leading private sector investment houses, providing a world-class platform for investment and growth. The company has a long-established track record of investing in public and private markets, deploying proprietary capital in alignment with third-party investors. The Public Markets business (operated by Waha Investment PrJSC, a wholly owned subsidiary) offers sophisticated investors actively managed emerging markets credit and equities funds, via a disciplined approach to investment and implementing distinctive strategies to deliver consistent market-leading returns. The Private Investments business pursues a multi-asset investment approach focused on direct investments, with the flexibility to deploy capital across diverse sectors and geographies. The business leverages extensive international business networks to source deals and form co-investment partnerships. The Waha Land business develops and leases industrial and logistics facilities at ALMARKAZ in Abu Dhabi's Al Dhafra region, strategically leveraging the UAE's expanding industrial infrastructure, to grow its institutional-grade assets and contribute to portfolio diversification and long-term value creation. Counting Mubadala Investment Company as an anchor shareholder, Waha Capital is at the forefront of Abu Dhabi's increasingly dynamic and entrepreneurial ecosystem, creating long-term value for shareholders, fund investors, employees, and communities.
